http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1801492-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d93da8eaac80ae6d1e582cd6bade79fa |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-46 |
| filingDate | 1991-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_106005ba12562d133c694f6e516a3d51 |
| publicationDate | 1993-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-1801492-C |
| titleOfInvention | Drug for treatment of patients with skin candidiasis |
| abstract | Use: to shorten the treatment of skin candidiasis. The invention contains levorin and ointment base, lysozyme is additionally introduced as an activating substance in the following ratio of components, May. %: levorin 1.25-2.5; lysozyme - 0.125-0.25; basis rest. The treatment period is 11-14 days. |
| priorityDate | 1991-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 45.